Systemic Treatment Before Surgery For Kidney Cancer Prolongs Patients' Survival

... Preliminary results from a phase II clinical trial have provided the first evidence that people with kidney cancer being treated with bevacizumab and erlotinib [1] before surgery is safe, effective and may prolong patients' survival.Renal cell carcinoma [2] (kidney cancer) is notoriously hard to treat, especially once it has started to spread to other sites in the body. [click link for full article] ...